A Day Up For Motif Bio plc
Tue 03 Dec 19 at 05:30 PM
Motif Bio plc (MTFB:NASDAQ) rocketted at $0.14, representing a gain of 50.1%. The stock appeared on our News Catalysts scanner on Wed 27 Nov 19 at 11:44 AM in the 'BIOTECH' category. From Mon 11 Nov 19, the stock recorded 35.71% Up Days and 26.67% Green Days
About Motif Bio plc (MTFB:NASDAQ)
Motif Bio PLC is a United Kingdom-based pharmaceutical products manufacturer. It is mainly focused on the development of antibiotic drugs to fight bacterial infections such as acute bacterial skin and skin structure infections.
Top 10 Gainers:
- Audentes Therapeutics, Inc. (BOLD:NASDAQ), 105.98%
- Quorum Health Corporation (QHC:NYSE), 65%
- Outlook Therapeutics, Inc. (OTLK:NASDAQ), 54.37%
- Motif Bio plc (MTFB:NASDAQ), 50.05%
- DarioHealth Corp. (DRIO:NASDAQ), 49.1%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 47.06%
- iBio, Inc. (IBIO:NYSEMKT), 41.35%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 41.01%
- Spirit Realty Capital, Inc. (SRC:NYSE), 40%
- Akerna Corp. (KERN:NASDAQ), 37.97%